A review of odd-chain fatty acid metabolism and the role of pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) in health and disease

Molecules

Volumn 20, Issue 2, 2015, Pages 2425-2444

  Jenkins, Benjamin ^a   West, James A ^a   Koulman, Albert ^a  

^a Elsie Widdowson Laboratory   (United Kingdom)

Author keywords

Biomarker; Dairy; Heptadecanoic; Odd chain fatty acids; Pentadecanoic; oxidation

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID; HEPTADECANOIC ACID; PENTADECANOIC ACID;

ANIMAL; BLOOD; CORONARY ARTERY DISEASE; HUMAN; LIPID METABOLISM; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ANIMALS; BIOLOGICAL MARKERS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; HUMANS; LIPID METABOLISM; RISK FACTORS;

EID: 84922041416     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules20022425     Document Type: Review

References (93)

1. Miettinen, T.A.; Railo, M.; Lepäntalo, M.; Gylling, H. Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J. Am. Coll. Cardiol. 2005, 45, 1794-1801.
2. Manninen, V.; Tenkanen, L.; Koskinen, P.; Huttunen, J.K.; Mänttäri, M.; Heinonen, O.P.; Frick, M.H. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the helsinki heart study. Implications for treatment. Circulation 1992, 85, 37-45.
3. Wang, L.; Folsom, A.R.; Zheng, Z.J.; Pankow, J.S.; Eckfeldt, J.H.; ARIC study investigators. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: The atherosclerosis risk in communities (ARIC) study. Am. J. Clin. Nutr. 2003, 78, 91-98.
4. Vlaeminck, B.; Fievez, V.; Cabrita, A.R.J.; Fonseca, A.J.M.; Dewhurst, R.J. Factors affecting odd- and branched-chain fatty acids in milk: A review. Anim. Feed Sci. Technol. 2006, 131, 389-417.
5. Reitz, C.; Tang, M.; Luchsinger, J.; Mayeux, R. Relation of plasma lipids to alzheimer disease and vascular dementia. Arch. Neurol. 2004, 61, 705-714.
6. LIPID Maps. Available online: http://www.lipidmaps.org/ (accessed on 28 January 2015).
7. Ulbricht, T.L.V.; Southgate, D.A.T. Coronary heart disease: Seven dietary factors. Lancet 1991, 338, 985-992.
8. Simopoulos, A.P. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 1991, 54, 438-463.
9. Izai, K.; Uchida, Y.; Orii, T.; Yamamoto, S.; Hashimoto, T. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme a dehydrogenase. J. Biol. Chem. 1992, 267, 1027-1033.
10. Poulos, A.; Sharp, P.; Fellenberg, A.J.; Danks, D.M. Cerebro-hepato-renal (zellweger) syndrome, adrenoleukodystrophy, and refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase. Hum. Genet. 1985, 70, 172-177.
11. Hodson, L.; Skeaff, C.M.; Fielding, B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47, 348-380.
12. Khaw, K.T.; Friesen, M.D.; Riboli, E.; Luben, R.; Wareham, N. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: The EPIC-norfolk prospective study. PLoS Med. 2012, 9, e1001255.
13. Çoker, M.; de Klerk, J.B.C.; Poll-The, B.T.; Huijmans, J.G.M.; Duran, M. Plasma total odd-chain fatty acids in the monitoring of disorders of propionate, methylmalonate and biotin metabolism. J. Inherit. Metab. Dis. 1996, 19, 743-751.
14. Phillips, G.B.; Dodge, J.T. Composition of phospholipids and of phospholipid fatty acids of human plasma. J. Lipid Res. 1967, 8, 676-681.
15. Horning, M.G.; Martin, D.B.; Karmen, A.; Vagelos, P.R. Fatty acid synthesis in adipose tissue II. Enzymatic synthesis of branched chain and odd-numbered fatty acids. J. Biol. Chem. 1961, 236, 669-672.
16. Mead, J.F.; Gabriel, M. Levis. A 1 Carbon degradation of the long chain fatty acids of brain sphingolipids. J. Biol. Chem. 1963, 238, 1634-1636.
17. Vanitallie, T.B.; Khachadurian, A.K. Rats enriched with odd-carbon fatty acids: Maintenance of liver glycogen during starvation. Science 1969, 165, 811-813.
18. Jansen, G.A.; Ronald, J.A. Wanders. Alpha-oxidation. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 2006, 1763, 1403-1412.
19. Ferrannini, E.; Barrett, E.J.; Bevilacqua, S.; DeFronzo, R.A. Effect of fatty acids on glucose production and utilization in man. J. Clin. Investig. 1983, 72, 1737-1747.
20. Nestel, P.J.; Straznicky, N.; Mellett, N.A.; Wong, G.; De Souza, D.P.; Tull, D.L.; Barlow, C.K.; Grima, M.T.; Meikle, P.J. Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. Am. J. Clin. Nutr. 2014, 99, 46-53.
21. Sampson, D.; Hensley, W.J. A rapid gas chromatographic method for the quantitation of underivatised individual free fatty acids in plasma. Clin. Chim. Acta 1975, 61, 1-8.
22. Novgorodtseva, T.P.; Karaman, Y.K.; Zhukova, N.V.; Lobanova, E.G.; Antonyuk, M.V.; Kantur, T.A. Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome. Lipids Health Dis. 2011, 10, 82.
23. Hellmuth, C.; Demmelmair, H.; Schmitt, I.; Peissner, W.; Blüher, M.; Koletzko, B. Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PLoS One 2013, 8, e74927.
24. Baylin, A.; Kim, M.K.; Donovan-Palmer, A.; Siles, X.; Dougherty, L.; Tocco, P.; Campos, H. Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am. J. Epidemiol. 2005, 162, 373-381.
25. Quehenberger, O.; Armando, A.M.; Brown, A.H.; Milne, S.B.; Myers, D.S.; Merrill, A.H.; Bandyopadhyay, S.; Jones, K.N.; Kelly, S.; Shaner, R.L.; et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J. Lipid Res. 2010, 51, 3299-3305.
26. Matthan, N.R.; Ooi, E.M.; van Horn, L.; Neuhouser, M.L.; Woodman, R.; Lichtenstein, A.H. Plasma phospholipid fatty acid biomarkers of dietary fat quality and endogenous metabolism predict coronary heart disease risk: A nested case-control study within the women's health initiative observational study. J. Am. Heart Assoc. 2014, 3, E000764.
27. Forouhi, N.G.; Koulman, A.; Sharp, S.J.; Imamura, F.; Kröger, J.; Schulze, M.B.; Crowe, F.L.; Huerta, J.M.; Guevara, M.; Beulens, J.W.; et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: The EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2014, doi:10.1016/S2213-8587(14)70146-9.
28. Saadatian-Elahi, M.; Slimani, N.; Chajès, V.; Jenab, M.; Goudable, J.; Biessy, C.; Ferrari, P.; Byrnes, G.; Autier, P.; Peeters, P.H.; et al. Plasma phospholipid fatty acid profiles and their association with food intakes: Results from a cross-sectional study within the European prospective investigation into cancer and nutrition. Am. J. Clin. Nutr. 2009, 89, 331-346.
29. Crowe, F.L.; Allen, N.E.; Appleby, P.N.; Overvad, K.; Aardestrup, I.V.; Johnsen, N.F.; Tjønneland, A.; Linseisen, J.; Kaaks, R.; Boeing, H.; et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European prospective investigation into cancer and nutrition. Am. J. Clin. Nutr. 2008, 88, 1353-1363.
30. Zák, A.; Vecka, M. Composition of plasma fatty acids and non-cholesterol sterols in anorexia nervosa. Physiol. Res. Acad. Sci. Bohemoslov. 2005, 54, 443-451.
31. Dyerberg, J.; Bang, H.O.; Hjorne, N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am. J. Clin. Nutr. 1975, 28, 958-966.
32. Ma, J.; Folsom, A.R.; Shahar, E.; Eckfeldt, J.H. Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The atherosclerosis risk in communities (ARIC) study investigators. Am. J. Clin. Nutr. 1995, 62, 564-571.
33. Caramia, G.; Cocchi, M. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture. Pediatr. Med. E Chir. Med. Surg. Pediatr. 2007, 25, 42-49.
34. Raatz, S.K.; Bibus, D.; Thomas, W.; Kris-Etherton, P. Total fat intake modifies plasma fatty acid composition in humans. J. Nutr. 2001, 131, 231-234.
35. Rúz-Gutiérrez, V.; Prada, J.L.; Pérez-Jiménez, F. Determination of fatty acid and triacylglycerol composition of human very-low-density lipoproteins. J. Chromatogr. B Biomed. Sci. Appl. 1993, 622, 117-124.
36. Skeaff, C.M.; Hodson, L.; McKenzie, J.E. Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J. Nutr. 2006, 136, 565-569.
37. Tserng, K.Y.; Kliegman, R.M.; Miettinen, E.L.; Kalhan, S.C. A rapid, simple, and sensitive procedure for the determination of free fatty acids in plasma using glass capillary column gas-liquid chromatography. J. Lipid Res. 1981, 22, 852-858.
38. Persson, X.M.; Blachnio-Zabielska, A.U.; Jensen, M.D. Rapid measurement of plasma free fatty acid concentration and isotopic enrichment using LC/MS. J. Lipid Res. 2010, 51, 2761-2765.
39. Kagan, M.L.; West, A.L.; Zante, C.; Calder, P.C. Acute appearance of fatty acids in human plasma-A comparative study between polar-lipid rich oil from the microalgae nannochloropsis oculata and krill oil in healthy young males. Lipids Health Dis. 2013, 12, 102.
40. Moser, A.B.; Kreiter, N.; Bezman, L.; Lu, S.; Raymond, G.V.; Naidu, S.; Moser, H.W. Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 1999, 45, 100-110.
41. Astrup, A. A changing view on saturated fatty acids and dairy: From enemy to friend. Am. J. Clin. Nutr. 2014, 100, 1407-1408.
42. Seppänen-Laakso, T.; Oresic, M. How to study lipidomes. J. Mol. Endocrinol. 2009, 42, 185-190.
43. Emmanuel, B. The relative contribution of propionate, and long-chain even-numbered fatty acids to the production of long-chain odd-numbered fatty acids in rumen bacteria. Biochim. Biophys. Acta (BBA) Lipids Lipid Metab. 1978, 528, 239-246.
44. Hughes, R. Definitions for public health nutrition: A developing consensus. Public Health Nutr. 2003, 6, 615-620.
45. Jeremiah, S. Diet and Coronary Heart Disease. Proceedings of "Current Topics in Biostatistics and Epidemiology". A Memorial Symposium in Honor of Jerome Cornfield. Biometrics 1982, 38, 95-114.
46. Smedman, A.E.; Gustafsson, I.B.; Berglund, L.G.; Vessby, B.O. Pentadecanoic acid in serum as a marker for intake of milk fat: Relations between intake of milk fat and metabolic risk factors. Am. J. Clin. Nutr. 1999, 69, 22-29.
47. Brevik, A.; Veierød, M.B.; Drevon, C.A.; Andersen, L.F. Evaluation of the odd fatty acids 15:0 and 17:0 in serum and adipose tissue as markers of intake of milk and dairy fat. Eur. J. Clin. Nutr. 2005, 59, 1417-1422.
48. Laliotis, G.P.; Bizelis, I.; Rogdakis, E. Comparative approach of the de novo fatty acid synthesis (lipogenesis) between ruminant and non-ruminant mammalian species: From biochemical level to the main regulatory lipogenic genes. Curr. Genomics 2010, 11, 168-183.
49. Or-Rashid, M.M.; Odongo, N.E.; McBride, B.W. Fatty acid composition of ruminal bacteria and protozoa, with emphasis on conjugated linoleic acid, vaccenic acid, and odd-chain and branched-chain fatty acids. J. Anim. Sci. 2007, 85, 1228-1234.
50. Dijkstra, J.; van Zijderveld, S.M.; Apajalahti, J.A.; Bannink, A.; Gerrits, W.J.J.; Newbold, J.R.; Perdok, H.B.; Berends, H. Relationships between methane production and milk fatty acid profiles in dairy cattle. Anim. Feed Sci. Technol. 2011, 166-167, 590-595.
51. French, E.A.; Bertics, S.J.; Armentano, L.E. Rumen and milk odd- and branched-chain fatty acid proportions are minimally influenced by ruminal volatile fatty acid infusions. J. Dairy Sci. 2012, 95, 2015-2026.
52. Heck, J.M.; van Valenberg, H.J.; Bovenhuis, H.; Dijkstra, J.; van Hooijdonk, T. Characterization of milk fatty acids based on genetic and herd parameters. J. Dairy Res. 2012, 79, 39-46.
53. Berthelot, V.; Bas, P.; Pottier, E.; Normand, J. The effect of maternal linseed supplementation and/or lamb linseed supplementation on muscle and subcutaneous adipose tissue fatty acid composition of indoor lambs. Meat Sci. 2012, 90, 548-557.
54. Dohme-Meier, F.; Bee, G. Feeding unprotected cla methyl esters compared to sunflower seeds increased milk CLA level but inhibited milk fat synthesis in cows. Asian Australas J. Anim. Sci. 2012, 25, 75-85.
55. Stefanov, I.; Baeten, V.; Abbas, O.; Vlaeminck, B.; De Baets, B.; Fievez, V. Evaluation of FT-NIR and ATR-FTIR spectroscopy techniques for determination of minor odd- and branched-chain saturated and trans unsaturated milk fatty acids. J. Agric. Food Chem. 2013, 61, 3403-3413.
56. Dewhurst, R.J.; Moorby, J.M.; Vlaeminck, B.; Fievez, V. Apparent recovery of duodenal odd- and branched-chain fatty acids in milk of dairy cows. J. Dairy Sci. 2007, 90, 1775-1780.
57. Fievez, V.; Colman, E.; Castro-Montoya, J.M.; Stefanov, I.; Vlaeminck, B. Milk odd- and branched-chain fatty acids as biomarkers of rumen function - An update. Anim. Feed Sci. Technol. 2012, 172, 51-65.
58. James, P.D.; Windhauser, M.M.; Champagne, C.M.; Bray, G.A. Differential oxidation of individual dietary fatty acids in humans. Am. J. Clin. Nutr. 2000, 72, 905-911.
59. Sun, Q.; Ma, J.; Campos, H.; Hu, F.B. Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am. J. Clin. Nutr. 2007, 86, 929-937.
60. Meikle, P.J.; Wong, G.; Barlow, C.K.; Weir, J.M.; Greeve, M.A.; MacIntosh, G.L.; Almasy, L.; Comuzzie, A.G.; Mahaney, M.C.; Kowalczyk, A.; et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013, 8, doi:10.1371/journal.pone.0074341.
61. Holman, R.T.; Johnson, S.B.; Kokmen, E. Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc. Natl. Acad. Sci. USA 1989, 86, 4720-4724.
62. Holman, R.T.; Adams, C.E.; Nelson, R.A.; Grater, S.J.; Jaskiewicz, J.A.; Johnson, S.B.; Erdman, J.W., Jr. Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J. Nutr. 1995, 125, 901-907.
63. Bazinet, R.P.; Layé, S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014, doi:10.1038/nrn3820.
64. Tan, Z.S.; Harris, W.S.; Beiser, A.S.; Au, R.; Himali, J.J.; Debette, S.; Pikula, A.; DeCarli, C.; Wolf, P.A.; Vasan, R.S.; et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology 2012, 78, 658-664.
65. Torres, M.; Price, S.L.; Fiol-deRoque, M.A.; Marcilla-Etxenike, A.; Ahyayauch, H.; Barceló-Coblijn, G.; Terés, S.; Katsouri, L.; Ordinas, M.; López, D.J.; et al. Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease. Biochim. Biophys. Acta (BBA) Biomembr. 2014, 1838, 1680-1692.
66. Haag, M. Essential fatty acids and the brain. Can. J. Psychiatry 2003, 48, 195-203.
67. Yang, X.; Sun, G.Y.; Eckert, G.P.; Lee, J.C.-M. Cellular membrane fluidity in amyloid precursor protein processing. Mol. Neurobiol. 2014, 50, 119-129.
68. Fonteh, A.N.; Cipolla, M.; Chiang, J.; Arakaki, X.; Harrington, M.G. Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease. PLoS One 2014, 9, e100519.
69. Shibata, R.; Gotoh, N.; Kubo, A.; Kanda, J.; Nagai, T.; Mizobe, H.; Yoshinaga, K.; Kojima, K.; Watanabe, H.; Wada, S. Comparison of catabolism rate of fatty acids to carbon dioxide in mice. Eur. J. Lipid Sci. Technol. 2012, 114, 1340-1344.
70. De Oliveira Otto, M.C.; Nettleton, J.A.; Lemaitre, R.N.; Steffen, L.M.; Kromhout, D.; Rich, S.S.; Tsai, M.Y.; Jacobs, D.R.; Mozaffarian, D. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the multi-ethnic study of atherosclerosis. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2013, 2, doi:10.1161/JAHA.113.000092.
71. Hodge, A.M.; English, D.R.; O'Dea, K.; Sinclair, A.J.; Makrides, M.; Gibson, R.A.; Giles, G.G. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: Interpreting the role of linoleic acid. Am. J. Clin. Nutr. 2007, 86, 189-197.
72. Mock, D.M.; Johnson, S.B.; Holman, R.T. Effects of biotin deficiency on serum fatty acid composition: evidence for abnormalities in humans. J. Nutr. 1988, 118, 342-348.
73. Moser, H.W.; Moser, A.B.; Frayer, K.K.; Chen, W.; Schulman, J.D.; O'Neill, B.P.; Kishimoto, Y. Adrenoleukodystrophy increased plasma content of saturated very long chain fatty acids. Neurology 1981, 31, 1241-1249.
74. Roe, C.R.; Sweetman, L.; Roe, D.S.; David, F.; Brunengraber, H. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J. Clin. Investig. 2002, 110, 259-269.
75. Mannaerts, G.P.; Van Veldhoven, P.P.; Casteels, M. Peroxisomal lipid degradation via beta- and alpha-oxidation in mammals. Cell Biochem. Biophys. 2000, 32, 73-87.
76. Eaton, S.; Bartlett, K.; Pourfarzam, M. Mammalian mitochondrial beta-oxidation. Biochem. J. 1996, Available online: http://www.biochemj.org/bj/320/bj3200345.htm (accessed on 29 January 2014).
77. Wierzbicki, A.S.; Lloyd, M.D.; Schofield, C.J,; Feher, M.D.; Gibberd, F.B. Refsum's disease: A peroxisomal disorder affecting phytanic acid α-oxidation. J. Neurochem. 2002, 80, 727-735.
78. Wanders, R.J.; Jansen, G.A.; Lloyd, M.D. Phytanic acid alpha-oxidation, new insights into an old problem: A review. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids 2003, 1631, 119-135.
79. Foulon, V.; Sniekers, M.; Huysmans, E.; Asselberghs, S.; Mahieu, V.; Mannaerts, G.P.; Veldhoven, P.P.V.; Casteels, M. Breakdown of 2-hydroxylated straight chain fatty acids via peroxisomal 2-hydroxyphytanoyl-coa lyase a revised pathway for the α-oxidation of straight chain fatty acids. J. Biol. Chem. 2005, 280, 9802-9812.
80. Guo, L.; Zhou, D.; Pryse, K.M.; Okunade, A.L.; Su, X. Fatty acid 2-hydroxylase mediates diffusional mobility of raft-associated lipids, glut4 level, and lipogenesis in 3t3-l1 adipocytes. J. Biol. Chem. 2010, 285, 25438-25447.
81. Kondo, N.; Ohno, Y.; Yamagata, M.; Obara, T.; Seki, N.; Kitamura, T.; Naganuma, T.; Kihara, A. Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids. Nat. Commun. 2014, 5, doi:10.1038/ncomms6338.
82. Nagy, K.; Brahmbhatt, V.V.; Berdeaux, O.; Bretillon, L.; Destaillats, F.; Acar, N. Comparative study of serine-plasmalogens in human retina and optic nerve: Identification of atypical species with odd carbon chains. J. Lipid Res. 2012, 53, 776-783.
83. Su, X.; Han, X.; Yang, J.; Mancuso, D.J.; Chen, J.; Bickel, P.E.; Gross, R.W. Sequential ordered fatty acid α oxidation and δ9 desaturation are major determinants of lipid storage and utilization in differentiating adipocytes. Biochemistry 2004, 43, 5033-5044.
84. Veldhoven, P.P.V. Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism. J. Lipid Res. 2010, 51, 2863-2895.
85. Yuki, D.; Sugiura, Y.; Zaima, N.; Akatsu, H.; Hashizume, Y.; Yamamoto, T.; Fujiwara, M.; Sugiyama, K.; Setou, M. Hydroxylated and non-hydroxylated sulfatide are distinctly distributed in the human cerebral cortex. Neuroscience 2011, 193, 44-53.
86. Valentine, N.H.; Richard, S. Hindmilk Improves Weight Gain in Low-Birth-Weight Infants Fe: Journal of Pediatric Gastroenterology and Nutrition. J. Pediatr. Gastr. Nutr. 1994. Available online: http://journals.lww.com/jpgn/Fulltext/1994/05000/Hindmilk-Improves-Weight-Gain-in-Low-Birth-Weight.13.aspx (accessed on 31 January 2014).
87. Roberts, L.D.; Virtue, S.; Vidal-Puig, A.; Nicholls, A.W.; Griffin, J.L. Metabolic phenotyping of a model of adipocyte differentiation. Physiol. Genomics 2009, 39, 109-119.
88. Labarthe, F.; Gélinas, R.; Rosiers, C.D. Medium-chain fatty acids as metabolic therapy in cardiac disease. Cardiovasc. Drugs Ther. 2008, 22, 97-106.
89. Jacobs, S.; Schiller, K.; Jansen, E.; Fritsche, A.; Weikert, C.; di Giuseppe, R.; Boeing, H.; Schulze, M.B.; Kröger, J. Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study. Eur. J. Clin. Nutr. 2014, 68, 517-525.
90. Mozaffarian, D. Saturated fatty acids and type 2 diabetes: More evidence to re-invent dietary guidelines. Lancet Diabetes Endocrinol. 2014, 2, 770-772.
91. Sbaï, D.; Narcy, C.; Thompson, G.N.; Mariotti, A.; Poggi, F.; Saudubray, J.M.; Bresson, J.L. Contribution of odd-chain fatty acid oxidation to propionate production in disorders of propionate metabolism. Am. J. Clin. Nutr. 1994, 59, 1332-1337.
92. Gozzo, S.; Oliverio, A.; Salvati, S.; Serlupi-Crescenzi, G.; Tagliamonte, B.; Tomassi, G. Effects of dietary phospholipids and odd-chain fatty acids on the behavioural maturation of mice. Food Chem. Toxicol. 1982, 20, 153-157.
93. Brass, E.P.; Beyerinck, R.A. Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids. Biochem. J. 1988. Available online: http://www.biochemj.org/bj/250/bj2500819.htm (accessed on 15 January 2014).